Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description adds substantial behavioral context beyond these: it discloses that LEI/FIGI enrichment degrades gracefully when external sources are unavailable, that unresolved identifiers are explicitly listed under `unresolved` rather than omitted, that ambiguous name matches assert nothing and return candidates, and that it cascades through multiple internal endpoints. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and well-structured, with examples up front and then organized by supported type. It is longer than average but every sentence carries information (edge cases, degradation, input rules). The structure is logical (examples → 'use first' → types → enrichment behavior → efficiency note). Minor deduction for length—it could be slightly tightened without loss, but it is certainly not padded.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple identifier sources, ambiguity handling, graceful degradation) and the absence of an output schema, the description is remarkably complete. It covers input formats, output expectations (including `figi_candidates` and `unresolved` fields), source attribution, and failure modes. An agent has all necessary information to decide when to call it and what to pass, even without seeing any example output.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the baseline is 3. However, the description goes well beyond the schema: it explains the `value` parameter's semantics with concrete examples (ticker, CIK, ISIN, or name for company; brand/generic for drug), warns against including trailing security-class words, and specifies how ISINs resolve to legal entities via GLEIF. It also clarifies the `type` enum's implications, such as non-equity instruments resolving under 'company'. This adds meaning the schema alone does not provide.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific purpose: resolving user-spoken names to canonical/official identifiers. It provides numerous concrete query examples ('What's the ticker for…', 'find the CIK for…') and explicitly enumerates supported types ('company', 'drug') and the identifier sources (SEC EDGAR, GLEIF, OpenFIGI, RxNorm). This clearly distinguishes it from sibling tools like entity_profile or validate_claim, which likely serve different lookup/verification functions.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit usage direction: 'Use FIRST whenever you have a name but need an ID.' It also explains when the tool deliberately refuses to assert an identifier (ambiguous matches return `figi_candidates`), how to handle input formatting (pass entity name only, not full noun phrase), and that it replaces 2-3 manual lookups. No alternative tools are named, but the 'use first' directive is strong and the edge-case guidance is detailed.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation1/5

The tool set is severely mismatched: only 3 of 34 tools (get_pathway, list_pathways, search_pathways) relate to WikiPathways while the rest form overlapping Pipeworx/Polymarket families (ask_pipeworx vs ask_pipeworx_beta vs ask_pipeworx_grounded; multiple polymarket_* tools) with unclear boundaries and overlapping purposes.

Naming Consistency2/5

Naming conventions are highly inconsistent: product-specific names (pipeworx_feedback, pipeworx_trending), generic memory verbs (remember, recall, forget), and mixed snake_case patterns with no unifying verb_noun structure. The names do not reflect the WikiPathways domain at all.

Tool Count1/5

34 tools is far too many for a WikiPathways server, which only needs a handful of pathway-related operations. Nearly all tools belong to unrelated domains (SEC, FDA, Polymarket, npm, etc.), making the set feel bloated and unfocused.

Completeness1/5

For the stated WikiPathways purpose, only get, list, and search are present—no create, update, or delete operations—leaving obvious lifecycle gaps. The extensive non-WikiPathways tools do not contribute to the server's apparent domain coverage and create dead ends for agents expecting pathway management.